COMPASS CAPITAL MANAGEMENT, INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 870 filers reported holding NOVARTIS A G in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.

Quarter-by-quarter ownership
COMPASS CAPITAL MANAGEMENT, INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2018$25,222,000
+2.3%
333,890
+9.5%
3.67%
-0.5%
Q1 2018$24,654,000
+0.0%
304,931
+3.9%
3.69%
-1.0%
Q4 2017$24,648,000
+1.2%
293,569
+3.4%
3.73%
-3.7%
Q3 2017$24,367,000
+3.3%
283,838
+0.5%
3.87%
+0.8%
Q2 2017$23,583,000
+13.6%
282,530
+1.1%
3.84%
+7.5%
Q1 2017$20,760,000
+5.0%
279,521
+2.9%
3.58%
-3.2%
Q4 2016$19,779,000
-0.1%
271,536
+8.3%
3.69%
-0.6%
Q3 2016$19,796,000
-2.9%
250,715
+1.4%
3.72%
-4.7%
Q2 2016$20,396,000
+31.3%
247,197
+15.3%
3.90%
+26.1%
Q1 2016$15,528,000
-9.3%
214,352
+7.7%
3.09%
-14.8%
Q4 2015$17,129,000
-1.7%
199,081
+5.1%
3.63%
-7.2%
Q3 2015$17,418,000
-6.0%
189,496
+0.6%
3.91%
-0.1%
Q2 2015$18,528,000
-1.3%
188,406
-1.0%
3.91%
+0.1%
Q1 2015$18,764,000
+7.8%
190,283
+1.3%
3.91%
+5.1%
Q4 2014$17,402,000
-2.0%
187,802
-0.5%
3.72%
+8.7%
Q3 2014$17,760,000
+3.6%
188,673
-0.4%
3.42%
+3.1%
Q2 2014$17,141,000
+4.4%
189,340
-2.0%
3.32%
+1.1%
Q1 2014$16,419,000
+6.8%
193,118
+1.0%
3.28%
+5.7%
Q4 2013$15,372,000
+6.5%
191,243
+1.6%
3.10%
-4.6%
Q3 2013$14,437,000
+10.9%
188,197
+2.2%
3.25%
+2.6%
Q2 2013$13,021,000184,1413.17%
Other shareholders
NOVARTIS A G shareholders Q1 2016
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders